Dr. Craig Shimasaki, President and CEO of Moleculera Labs, discusses the science behind infection-triggered autoimmune encephalopathies, such as basal ganglia encephalitis, PANS and PANDAS and utilization of the Cunningham Panel of tests as an aid in diagnosis and treatment for such conditions.
11 окт 2024